Thor Medical ASA Cash Flow-to-Debt Ratio
Thor Medical ASA cash flow-to-debt ratio. Thor Medical ASA (TRMED) has a Cash Flow-to-Debt Ratio of -0.19x as of December 2025, meaning its operating cash flow of Nkr-47.54 Million could theoretically repay 0% of its total liabilities (Nkr252.64 Million) in one year. See TRMED FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Thor Medical ASA (2019–2025)
Cash flow-to-debt ratio of Thor Medical ASA from 2019 to 2025. Historical debt coverage capacity for Thor Medical ASA across 7 annual periods. See Thor Medical ASA balance sheet quality to measure how much of total assets are equity-financed.
Thor Medical ASA Cash Flow-to-Debt Ratio by Year (2019–2025)
Thor Medical ASA cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Thor Medical ASA. For the full cash flow conversion analysis, see Thor Medical ASA (TRMED) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.19x | Nkr-47.54 Million | Nkr252.64 Million | ▲ +38.6% |
| 2024 | -0.31x | Nkr-23.70 Million | Nkr77.30 Million | ▲ +71.8% |
| 2023 | -1.09x | Nkr-64.09 Million | Nkr58.91 Million | ▲ +87.8% |
| 2022 | -8.93x | Nkr-409.08 Million | Nkr45.80 Million | ▼ -245.7% |
| 2021 | -2.58x | Nkr-403.46 Million | Nkr156.16 Million | ▲ +11.8% |
| 2020 | -2.93x | Nkr-398.21 Million | Nkr135.94 Million | ▲ +96.7% |
| 2019 | -89.83x | Nkr-410.62 Million | Nkr4.57 Million | — |